Physical Therapy for Patients with Cardiovascular Disease.

Pre-travel Health Advice for Patients With Cardiovascular Disease

Cardiovascular disease (CVD) is the leading cause of death among international travellers. Practitioner knowledge of the effects of CVD on international travel is imperative in order to promote a healthy travel experience. This review aimed to explore the available literature on this topic. The PubMed database was accessed to source relevant literature using combinations of relevant keywords as...

Cell Therapy in Cardiovascular Disease

  Recently, cell therapy has sparked a revolution in ischemic heart disease that will in the future help clinicians to cure patients. Earlier investigations in animal models and clinical trials have suggested that positive paracrine effects such as neoangiogenesis and anti-apoptotic can improve myocardial function. In this regard the Royan cell therapy center designed a few trials in collaborat...

Controversies in antiplatelet therapy for patients with cardiovascular disease.

Case presentation: An asymptomatic man (J.D.) is referred for a cardiovascular evaluation. He has a strong family history of coronary artery disease and has received more than 10 years of treatment for hypertension and dyslipidemia. Past medical history is significant for symptomatic degenerative joint disease. Medications include hydrochlorothiazide, lisinopril, atorvastatin, and celecoxib. Ho...

The Effects of Physical Therapy for Patients with Parkinson’s Disease

Soluble Adiponectin is a New Predictor for Cardiovascular Complications in Patients with End Stage Renal Disease

Mortality due to cardiovascular complications (CVC) in patients with end stage renal disease (ESRD) is 20 fold higher than in general population. Adiponectin (ADPN) hormone from adipose tissues accumulation in serum is attributed to reduced renal clearance. The aim of this study was to investigate the possible role of ADPN as a predictor of CVC in adult patients with ESRD on hemodialysis (HD), ...